Biopharm Closing Bell: 7.1.08

Gainers (% price change)
Last Trade
Change
Mkt Cap

NxStage Medical, Inc.
NXTM
4.42
+0.58 (15.10%)
162.63M

Myriad Genetics, Inc.
MYGN
51.39
+5.87 (12.90%)
2.29B

The Aristotle Corporation
ARTL
8.38
+0.92 (12.33%)
150.52M

DepoMed, Inc.
DEPO
3.50
+0.29 (9.03%)
168.09M

Celgene Corporation
CELG
69.26
+5.39 (8.44%)
30.19B

Losers (% price change)
 

Senomyx Inc.
SNMX
4.23
-0.70 (-14.20%)
129.39M

Protherics PLC (ADR)
PTIL
6.50
-0.74 (-10.22%)
220.49M

Marshall Edwards, Inc.
MSHL
2.31
-0.26 (-10.12%)
159.05M

Optimer Pharmaceuticals,
OPTR
7.36
-0.75 (-9.25%)
205.53M

MiddleBrook
MBRK
3.07
-0.31 (-9.17%)
171.94M

Most Actives (dollar volume)
 

Celgene Corporation
CELG
69.26
+5.39 (8.44%)
30.19B

Johnson & Johnson
JNJ
64.69
+0.35 (0.54%)
182.31B

Pfizer Inc.
PFE
17.73
+0.26 (1.49%)
119.95B

Merck & Co., Inc.
MRK
38.36
+0.67 (1.78%)
82.34B

Amgen, Inc.
AMGN
48.64
+1.48 (3.14%)
52.95B

Top Biopharma Deals Q1 ‘08

It’s a just a quarter of the way into 2008 and it is clear the both large
biotech and pharma have holes to fill in thier pipeline. Six deals have
already been inked that total over a half a billion bio-dollars each.
Below are 4 of the top deals thus far:
Genzyme/Isis ($1,900M) - Genzyme paid Isis $175M in
cash [...]